We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Floor & Decor
FND
$6.46B
| $794K | ﹤0.01% |
8,081
| – | – |
|
1177
LCI Industries
LCII
$2.6B
| $790K | ﹤0.01% |
7,188
+1,298
| +22% | +$142K |
|
1178
SM Energy
SM
$7.45B
| $786K | ﹤0.01% |
27,900
| – | – |
|
|
PFTA
1179
DELISTED
Perception Capital Corp. III Class A Ordinary Share
PFTA
| $781K | ﹤0.01% |
101,332
| – | – |
|
1180
JD.com
JD
$44.5B
| $777K | ﹤0.01% |
17,709
-1,200
| -6% | -$62K |
|
1181
Century Communities
CCS
$2B
| $773K | ﹤0.01% |
12,100
-800
| -6% | -$47.7K |
|
1182
Keros Therapeutics
KROS
$202M
| $773K | ﹤0.01% |
18,100
+8,100
| +81% | +$409K |
|
1183
Ares Management
ARES
$32.2B
| $771K | ﹤0.01% |
9,239
-400
| -4% | -$31.8K |
|
|
VGR
1184
DELISTED
Vector Group Ltd.
VGR
| $767K | ﹤0.01% |
+63,900
| New | +$806K |
|
|
THR
1185
DELISTED
Thermon Group Holdings
THR
| $758K | ﹤0.01% |
30,432
| – | – |
|
1186
Equitable Holdings
EQH
$13.2B
| $752K | ﹤0.01% |
29,633
+1,193
| +4% | +$35.2K |
|
1187
Jazz Pharmaceuticals
JAZZ
$16.4B
| $750K | ﹤0.01% |
5,122
+195
| +4% | +$28.8K |
|
|
EFXT
1188
Enerflex
EFXT
$2.72B
| $748K | ﹤0.01% |
125,685
-1,009,217
| -89% | -$6.61M |
|
1189
Cadre Holdings
CDRE
$1.32B
| $747K | ﹤0.01% |
34,702
+1,800
| +5% | +$38.9K |
|
1190
United Therapeutics
UTHR
$22B
| $742K | ﹤0.01% |
+3,313
| New | +$817K |
|
1191
Owens Corning
OC
$11.7B
| $739K | ﹤0.01% |
7,718
+242
| +3% | +$22.9K |
|
1192
Applied Industrial Technologies
AIT
$13.2B
| $739K | ﹤0.01% |
5,200
+1,300
| +33% | +$176K |
|
1193
Pennant Group
PNTG
$1.34B
| $738K | ﹤0.01% |
51,654
| – | – |
|
1194
Sanmina
SANM
$11.1B
| $732K | ﹤0.01% |
12,000
-5,500
| -31% | -$329K |
|
1195
Dropbox
DBX
$8.04B
| $727K | ﹤0.01% |
33,625
+2,604
| +8% | +$57.1K |
|
|
INFN
1196
DELISTED
Infinera Corporation Common Stock
INFN
| $723K | ﹤0.01% |
93,190
+36,800
| +65% | +$268K |
|
1197
Bank OZK
OZK
$5.7B
| $722K | ﹤0.01% |
21,107
-256,230
| -92% | -$10.8M |
|
1198
Vaxcyte
PCVX
$7.89B
| $720K | ﹤0.01% |
19,200
+5,644
| +42% | +$239K |
|
1199
Iovance Biotherapeutics
IOVA
$1.96B
| $713K | ﹤0.01% |
116,656
+2,000
| +2% | +$13.8K |
|
1200
RLI Corp
RLI
$5.67B
| $704K | ﹤0.01% |
10,600
-7,600
| -42% | -$505K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.